register

Digital & Innovation

Report highlights digital health industry engagement with Australian regulatory framework

Health Industry Hub | March 3, 2021 |

Digital & Innovation: Digital health technologies (DHTs) have the potential to disrupt both the medical technology, biotechnology and pharmaceutical sector and the broader delivery of healthcare, creating challenges for the effective and timely regulation of new therapeutic goods.

MTPConnect’s new report Adaptive Regulation for Digital Health: Enhancing Australia’s Regulation System examines how digital health industry stakeholders are engaging with the Australian therapeutic goods regulatory framework, using case studies to highlight the rapid and diverse development pathways for digital medical devices in Australia.

Focusing on DHTs regulated as medical devices – including software as a medical device (SaMD) and physical medical devices with associated software – the research has sought to cover the following:

International Women's Day 2021 - Health Industry Hub
Interview links will be provided via email next week.
  1.  Ascertain the current state of knowledge regarding regulatory pathways and regulation compliance for DHTs;
  2. Identify key challenges in digital health regulation within the current regulatory framework;
  3. Identify potential alignments and misalignments between current regulatory requirements and new product development processes;
  4. Clarify how current regulatory policies and frameworks could accommodate an adaptive approach to digital health regulation; and
  5. Identify areas where greater education and awareness are needed within industry.

The research presented in this report was funded by MTPConnect and conducted by researchers at The University of Queensland’s (UQ) Australian Institute for Business and Economics (AIBE) with support from Steering Committee representatives from the Therapeutic Goods Administration, CSIRO, ANDHealth, University of Queensland and Allens.

Australia has an opportunity to take the global lead in ensuring timely consumer access to cutting-edge medical technologies. This report is critical reading for start-ups and innovators developing digital health technologies.

Click here to view the report.


News & Trends - MedTech & Diagnostics

Roche Diagnostics MD bids farewell after two-decades, leading the organisation to new heights of success

Roche Diagnostics MD bids farewell after two-decades, leading the organisation to new heights of success

Health Industry Hub | April 19, 2024 |

Diagnostics & MedTech News: The Managing Director of Roche Diagnostics Australia, Allison Rossiter, has announced her resignation, effective September 2024. […]

More


News & Trends - Pharmaceuticals

Is Australia ready to play a leading role in precision nuclear medicines?

Is Australia ready to play a leading role in precision nuclear medicines?

Health Industry Hub | April 19, 2024 |

Pharma News: A newly released discussion paper unveils Australia’s preparedness to take the helm in the rise of the global […]

More


News & Trends - MedTech & Diagnostics

Minimally invasive procedure a first in epilepsy treatment

Minimally invasive procedure a first in epilepsy treatment

Health Industry Hub | April 19, 2024 |

MedTech & Diagnostics News: An Australian-first procedure utilising MRI-guided, minimally invasive surgery has been introduced for the treatment of epilepsy […]

More


News & Trends - Pharmaceuticals

BCNA joins international call to tackle breast cancer gaps and inequities

Stakeholders unite in international call to tackle breast cancer gaps and inequities

Health Industry Hub | April 19, 2024 |

Pharma News: Breast Cancer Network Australia (BCNA) has united in an international call to raise breast cancer care standards and […]

More


This content is copyright protected. Please subscribe to gain access.